Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Ribociclib CAS 1211441-98-3 Active Pharmaceutical Ingredient Raw Material

Ribociclib CAS 1211441-98-3 Active Pharmaceutical Ingredient Raw Material

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1211441-98-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

Ribociclib CAS 1211441-98-3

,

Ribociclib Active Pharmaceutical Ingredient

,

1211441-98-3 Active Pharmaceutical Ingredient

CAS NO::
1211441-98-3
Appearance::
White To Off-white Powder
Molecular Formula::
C23H30N8O
Molecular Weight::
434.537
EINECS NO::
807-111-0
MDL NO::
MFCD27976795
CAS NO::
1211441-98-3
Appearance::
White To Off-white Powder
Molecular Formula::
C23H30N8O
Molecular Weight::
434.537
EINECS NO::
807-111-0
MDL NO::
MFCD27976795
Ribociclib CAS 1211441-98-3 Active Pharmaceutical Ingredient Raw Material

Product Description:

Product Name: Ribociclib CAS NO: 1211441-98-3

 

 

Synonyms:

7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide;

LEE 011;

 

 

Chemical & Physical Properties:

Appearance: White to off-white powder

Assay :≥99.0%

Density:1.39g/cm3

Boiling Point:730.8℃ at 760 mmHg

Flash Point:395.8℃

Solubility: Soluble in DMSO, not soluble in water.

 

 

Description:

Ribociclib Free Base, also known as LEE011, is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. CDK4/6 inhibitor LEE011 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.

 

 

Related CAS#

1211441-98-3 (Ribociclib free base)

1211443-80-9 (Ribociclib hydrochloride)

1374639-75-4 (Ribociclib succinate)

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.